ALPA LABORATORIES
Back to Balance Sheet
|
ALPA LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹4.49 Cr | ₹2.40 Cr | ₹3.06 Cr | ₹4.70 Cr | ₹0.23 Cr |
What is the latest Total Non-Current Liabilities ratio of ALPA LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹4.49 Cr |
| Mar2024 | ₹2.40 Cr |
| Mar2023 | ₹3.06 Cr |
| Mar2022 | ₹4.70 Cr |
| Mar2021 | ₹0.23 Cr |
How is Total Non-Current Liabilities of ALPA LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.49 Cr | 87.52 | |
| Mar2024 | ₹2.40 Cr | -21.70 | |
| Mar2023 | ₹3.06 Cr | -34.82 | |
| Mar2022 | ₹4.70 Cr | 1,986.67 | |
| Mar2021 | ₹0.23 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALPA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALPA LABORATORIES | ₹149.9 Cr | 2% | 2.4% | -32.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,980.0 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
ALPA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALPA LABORATORIES | 2% |
2.4% |
-32.4% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses